We are live on
!
Find out more
ACM
Atika Capital Management Portfolio holdings
AUM
$796M
1-Year Est. Return
167.57%
This Fund
S&P 500
This Quarter
Est. Return
+10.23%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$123M
AUM Growth
+$5.54M
(+4.7%)
Cap. Flow
-$158K
Cap. Flow
% of AUM
-0.13%
Top 10 Holdings %
Top 10 Hldgs %
35.93%
Holding
93
New
32
Increased
10
Reduced
17
Closed
31
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MYCC
ClubCorp Holdings, Inc.
MYCC
|
+$4.82M |
| 2 |
AbbVie
ABBV
|
+$3.75M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$3.28M |
| 4 |
SHPG
Shire pic
SHPG
|
+$2.96M |
| 5 |
TripAdvisor
TRIP
|
+$2.82M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Incyte
INCY
|
+$3.61M |
| 2 |
TW
TOWERS WATSON & CO COM STK CL A (DE)
TW
|
+$3.47M |
| 3 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$3M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$2.83M |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$2.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.6% |
| 2 | Communication Services | 11.98% |
| 3 | Industrials | 8.33% |
| 4 | Consumer Discretionary | 7.51% |
| 5 | Materials | 7.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HNT
26
DELISTED
HEALTH NET INC
HNT
| $1.99M | 1.62% |
+48,000
| New | +$1.79M |
|
27
Caesarstone
CSTE
$69.5M
| $1.96M | 1.6% |
40,000
-1,500
| -4% | -$76.3K |
|
|
ENDP
28
DELISTED
Endo International plc
ENDP
| $1.96M | 1.59% |
28,000
-6,480
| -19% | -$433K |
|
|
EQM
29
DELISTED
EQM Midstream Partners, LP
EQM
| $1.94M | 1.57% |
+20,000
| New | +$1.63M |
|
30
Veracyte
VCYT
$4.45B
| $1.93M | 1.57% |
112,500
+11,300
| +11% | +$163K |
|
|
ALXN
31
DELISTED
Alexion Pharmaceuticals
ALXN
| $1.88M | 1.52% |
+12,000
| New | +$1.89M |
|
|
GMCR
32
DELISTED
KEURIG GREEN MTN INC
GMCR
| $1.87M | 1.52% |
+15,000
| New | +$1.64M |
|
33
ICICI Bank
IBN
$107B
| $1.68M | 1.37% |
+185,350
| New | +$1.6M |
|
|
AGN
34
DELISTED
Allergan plc
AGN
| $1.67M | 1.36% |
+7,500
| New | +$1.55M |
|
|
NPSP
35
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $1.55M | 1.26% |
+47,000
| New | +$1.36M |
|
|
LCI
36
DELISTED
Lannett Company, Inc.
LCI
| $1.49M | 1.21% |
7,500
-4,125
| -35% | -$649K |
|
37
NRG Energy
NRG
$26.2B
| $1.49M | 1.21% |
+40,000
| New | +$1.38M |
|
38
Bausch Health
BHC
$1.75B
| $1.45M | 1.18% |
+11,500
| New | +$1.47M |
|
|
ANAC
39
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $1.28M | 1.04% |
72,000
-20,900
| -22% | -$336K |
|
40
Gogo Inc
GOGO
$525M
| $1.27M | 1.03% |
65,000
-7,000
| -10% | -$121K |
|
41
Alnylam Pharmaceuticals
ALNY
$38.3B
| $1.26M | 1.03% |
+20,000
| New | +$1.19M |
|
42
PUT
Invesco QQQ Trust
QQQ
$436B
| $1.16M | 0.95% |
+12,400
| New | +$1.11M |
|
|
SWC
43
DELISTED
Stillwater Mining Co
SWC
| $1.09M | 0.88% |
+61,900
| New | +$1.01M |
|
44
JetBlue
JBLU
$2.16B
| $1.08M | 0.88% |
+100,000
| New | +$924K |
|
|
BOBE
45
DELISTED
Bob Evans Farms, Inc.
BOBE
| $1.05M | 0.85% |
21,000
-8,925
| -30% | -$424K |
|
46
CALL
Bristol-Myers Squibb
BMY
$129B
| $970K | 0.79% |
20,000
| – | – |
|
|
KEYW
47
PUT
DELISTED
The KEYW Holding Corporation
KEYW
| $894K | 0.73% |
+71,100
| New | +$886K |
|
|
AMRI
48
DELISTED
Albany Molecular Research Inc
AMRI
| $873K | 0.71% |
43,400
-31,100
| -42% | -$527K |
|
49
Astronics
ATRO
$3.21B
| $865K | 0.7% |
+33,569
| New | +$872K |
|
|
AVDL
50
DELISTED
Avadel Pharmaceuticals
AVDL
| $855K | 0.7% |
+57,000
| New | +$688K |
|
Similar funds
AGA
RIM
ACM
CAM
LSA
GWA
HP
Atika Capital Management's Q2 2014 Portfolio in Review
As of Q2 2014, Atika Capital Management held 93 positions worth $123M, up 4.7% from $117M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Atika Capital Management's Q2 2014 filing shows 32 new, 10 increased, 17 reduced and 31 closed positions. Its largest new stake was ClubCorp Holdings, Inc.: 262,000 shares worth $4.86M. The largest sale was Incyte, an estimated $3.61M.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 37% a quarter earlier, followed by Communication Services and Industrials.
- Atika Capital Management's largest Q2 2014 buy was ClubCorp Holdings, Inc.: 262,000 shares worth $4.86M.
- Atika Capital Management added most to INTERMUNE INC in Q2 2014, an estimated $2.17M increase.
- Atika Capital Management's biggest Q2 2014 reduction was Intercept Pharmaceuticals, Inc., cutting an estimated $3M.
- Atika Capital Management fully exited Incyte in Q2 2014, selling an estimated $3.61M.
- Atika Capital Management's ten largest holdings make up 36% of its $123M portfolio in Q2 2014.
- Atika Capital Management opened 32 new positions and closed 31 in Q2 2014.
- Atika Capital Management's portfolio value rose 4.7% quarter-over-quarter to $123M.
Based on Atika Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.